- 2301. INSULIN HUMAN
- (UMLS (NCI) C0795635) Insulin, Human;
INSULIN,REGULAR,HUMAN BUFFERED;
INSULIN,REGULAR,HUMAN BUFFERED PREPARATION;
INSULIN,REGULAR,HUMAN/rDNA;
INSULIN,REGULAR,HUMAN/rDNA PREPARATION;
INSULIN,REGULAR,HUMAN/SEMISYNTHETIC;
INSULIN,REGULAR,HUMAN/SEMISYNTHETIC PREPARATION;
Regular Insulin, Human =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone =[HS501] INSULIN;
Unclassified Ingredients =INSULIN,REGULAR,HUMAN BUFFERED 100 UNT/ML;
INSULIN,REGULAR,HUMAN/SEMISYNTHETIC 100 UNT/ML;
INSULIN,REGULAR,HUMAN/SEMISYNTHETIC 30 UNT/ML;
INSULIN,REGULAR,HUMAN/rDNA 100 UNT/ML;
INSULIN,REGULAR,HUMAN/rDNA 500 UNT/ML;
INSULIN,REGULAR,HUMAN/rDNA 30 UNT/ML;
INSULIN,REGULAR,HUMAN/rDNA 50 UNT/ML | - 2351. INT INF E COLI ENTRPATH
- (UMLS (ICD9CM) C0343380) =Disease or Syndrome
|
- 2302. insulin infusion system
- [Portable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor. ( MSH )] (UMLS (CSP) C0021648) =Medical Device
| - 2352. INT INF E COLI ENTRTOXGN
- (UMLS (ICD9CM) C0343379) =Disease or Syndrome
|
- 2303. insulin inhibitor
- [any substance or agent which suppresses, prevents or opposes the action of insulin. ( CSP )] (UMLS (CSP) C0021643) =Pharmacologic Substance =hormone antagonist;
| - 2353. INT INF E COLI SPCF NEC
- [ ] (UMLS (ICD9CM) C0494024) =Disease or Syndrome
|
- 2304. Insulin Pork
- (UMLS (NCI) C0770206) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
| - 2354. INT INF OTH GRM NEG BCTR
- (UMLS (ICD9CM) C0374932) =Disease or Syndrome
|
- 2305. insulin pump
- [An infusion pump is a device used in a health care facility to pump fluids into a patient in a controlled manner. The device may use a piston pump, a roller pump, or a peristaltic pump and may be powered electrically or mechanically. The device may also operate using a constant force to propel the fluid through a narrow tube which determines the flow rate. The device may include means to detect a fault condition, such as air in, or blockage of, the infusion line and to activate an alarm. ( SPN )] (UMLS (CSP) C1140609) =Medical Device
| - 2355. INT INF YRSNIA ENTRCLTCA
- (UMLS (ICD9CM) C0238528) =Disease or Syndrome
|
- 2306. INSULIN PUMP STATUS
- [ ] (UMLS (ICD9CM) C1260459) =Finding
| - 2356. INT THROMBOS HEMORRHOID
- [ ] (UMLS (ICD9CM) C0155781) =Acquired Abnormality; Disease or Syndrome
|
- 2307. Insulin Receptor Substrate 1
- [The protein IRS1 acts as an interface between signaling proteins with Src homology-2 domains (SH2 proteins) and the receptors for insulin, IGF2, growth hormone, several interleukins (IL4, IL9, IL13), and other cytokines. It regulates gene expression and stimulates mitogenesis and appears to mediate insulin/IGF1-stimulated glucose transport. (from OMIM 600797) ( NCI )] (UMLS (NCI) C0123658) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 2357. INT-1 Related Protein
- [The WNT2 protein is a secreted growth factor member of the INT1 gene family and is associated with breast cancer. WNT2 is expressed in a variety of fetal and adult human tissues. (from OMIM 147870 and NCI) ( NCI )] (UMLS (NCI) C0123987) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 2308. Insulin Receptor Substrate 1 Gene
- [This gene plays a role in signal transduction and carbohydrate metabolism. It is involved in mediation of the insulin response. ( NCI )] (UMLS (NCI) C1334140) IRS1;
IRS1 Gene;
=Gene or Genome ;
◊ [This gene is involved in signal transduction and is associated with Diabetes Mellitus. ( NCI )] (UMLS (NCI) C1334141) IRS2; IRS2 Gene; Gene or Genome ; | - 2358. INT/COMB VERSION NO EXTR
- [ ] (UMLS (ICD9CM) C0195743) =Therapeutic or Preventive Procedure
|
- 2309. Insulin Receptor Substrate 2
- [Similar in function to IRS1; insulin receptor substrate 2 is a cytoplasmic protein that contains many potential tyrosine and serine/threonine phosphorylation sites. Tyrosine-phosphorylated IRS2 protein has been shown to associate with cytoplasmic signalling molecules that contain SH2 domains. The IRS2 protein is phosphorylated by the insulin receptor tyrosine kinase upon receptor stimulation, as well as by an interleukin-4 receptor (IL4R) -associated kinase in response to IL4 treatment. (LocusLink) ( NCI )] (UMLS (NCI) C1334191) IRS2;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 2359. INT/COMB VERSION W EXTR
- [ ] (UMLS (ICD9CM) C0195744) =Therapeutic or Preventive Procedure
|
- 2310. Insulin Receptor Substrate 4
- [Similar in function to IRS1 and IRS2; insulin receptor substrate 4 is a cytoplasmic protein that contains many potential tyrosine and serine/threonine phosphorylation sites. Tyrosine-phosphorylated IRS4 protein has been shown to associate with cytoplasmic signalling molecules that contain SH2 domains. The IRS4 protein is phosphorylated by the insulin receptor tyrosine kinase upon receptor stimulation. ( NCI )] (UMLS (NCI) C0664773) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 2360. INT4
- [Encoded by human WNT3 Gene (WNT Family), 355-amino acid 39.6 kD (precursor) WNT-3 Protein is a wingless (Drosophila) homolog with 98% amino acid identity to mouse Wnt3 protein and 84% to human WNT3A protein. Highly-conserved structurally related WNT proteins are 350-400 amino acid, cysteine-rich, short-range putative paracrine signaling glycoprotein ligands for frizzled family seven transmembrane receptors involved in embryonic cell fate determination and patterning, as well as cell growth or differentiation in some adult mammalian tissues. Wnt3 is required in mouse primary axis formation and anterior-posterior neural patterning in the ectoderm. This protein may play a role in some cancers through activation of the WNT-beta-catenin-TCF signaling pathway. (from Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1504629) Wingless-Type MMTV Integration Site Family, Member 3 Protein;
WNT3;
WNT-3 Protein;
WNT-3 Proto-Oncogene Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 2311. Insulin Receptor Substrate 4 Gene
- [This gene plays a role in signal transduction and ligand binding. ( NCI )] (UMLS (NCI) C1334142) IRS4;
IRS4 Gene;
=Gene or Genome ;
| - 2361. Intact
- [Reproductively intact ( HL7V3.0 )] (UMLS (HL7) C1554187) =Idea or Concept =GenderStatus;
|
- 2312. insulin resistance
- [Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. It can be caused by the presence of INSULIN ANTIBODIES or the abnormalities in insulin receptors (RECEPTOR, INSULIN) on target cell surfaces. It is often associated with OBESITY; DIABETIC KETOACIDOSIS; INFECTION; and certain rare conditions. (from Stedman, 25th ed) ( MSH )] (UMLS (CSP) C0021655) =Pathologic Function
| - 2362. Intact
- [Undamaged in any way; whole. ( NCI )] (UMLS (NCI) C0205266) =Qualitative Concept
|
- 2313. insulin secretion
- [The regulated release of proinsulin from secretory granules (B granules) in the B cells of the pancreas; accompanied by cleavage of proinsulin to form mature insulin. [GOC:mah, ISBN:0198506732 "Oxford Dictionary of Biochemistry and Molecular Biology"] ( GO )] (UMLS (CSP) C1256369) =Cell Function ;
| - 2363. Intal
- (UMLS (NCI) C0591652) =Organic Chemical; Pharmacologic Substance
|
- 2314. insulin sensitivity
- [ ] (UMLS (CSP) C0920563) =Pathologic Function
| - 2364. INTCRAN VAR V LIG-STRIP
- [ ] (UMLS (ICD9CM) C0176647) =Therapeutic or Preventive Procedure
|
- 2315. insulin sensitivity/resistance
- [diminished effectiveness of insulin in raising or lowering blood sugar levels; it is associated with obesity, diabetes mellitus, ketoacidosis, infection, and certain rare conditions. ( CSP )] (UMLS (CSP) C0678154) =Pathologic Function ;
=drug resistance;
drug tolerance;
hormone sensitivity/resistance;
=metabolic syndrome;
| - 2365. Integer Number
- (UMLS (HL7) C1552680) =Quantitative Concept =Quantity;
|
- 2316. insulin tolerance
- [ ] (UMLS (CSP) C0598703) =Pathologic Function ;
| - 2366. Integral Membrane Protein
- [A protein that is an integral membrane protein with a transmembrane region. ( NCI )] (UMLS (NCI) C0021699) =Amino Acid, Peptide, or Protein; Receptor ;
|
- 2317. Insulin Zinc Injectable Suspension
- [A long-acting form of crystalline insulin often used in combination with a short-acting insulin in the treatment of diabetes mellitus. Administered once daily, this type of insulin may be derived from porcine, bovine, or recombinant sources. Endogenous human insulin, a pancreatic hormone composed of two polypeptide chains, is important for the normal metabolism of carbohydrates, proteins and fats; it has anabolic effects on many types of tissues. (NCI04) ( NCI )] (UMLS (NCI) C0041616) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
| - 2367. integrase
- [retrovirus encoded protein which covalently links the viral cDNA to host DNA; forms a 'preintegration complex' and catalyzes the viral integration reaction. ( CSP )] (UMLS (CSP) C0063690) =Amino Acid, Peptide, or Protein; Enzyme ;
=Viral Protein;
|
- 2318. Insulin, Lente
- [A long-acting crystalline insulin often used in combination with a short-acting insulin in the treatment of diabetes mellitus. This type of insulin may be derived from porcine or recombinant sources. Administered once daily, insulin Lente starts to lower blood glucose within 1 to 3 hours after injection and exerts its peak effect 7 to 15 hours after injection. Endogenous human insulin, a pancreatic hormone composed of two polypeptide chains, is important for the normal metabolism of carbohydrates, proteins and fats; it has anabolic effects on many types of tissues. (NCI04) ( NCI )] (UMLS (NCI) C0021659) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
| - 2368. Integrin Alpha-V
- [Human integrin alpha-V protein (1048 aa, ~116 kD) is encoded by the integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) gene (ITGAV). This type I membrane protein forms a heterodimer with an integrin beta protein (either the beta-1, 3, 5, 6 or 8 polypeptide). The resulting complex binds to the tripeptide R-G-D, an amino acid sequence present in a number of ligands including vitronectin, fibronectin, fibrinogen, and laminin. Ligand binding regulates cell adhesion, growth and migration. ( NCI )] (UMLS (NCI) C0253930) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 2319. Insulin, NPH
- [An intermediate-acting insulin used in the treatment of diabetes mellitus. Administered once or twice daily, NPH (neutral protamine hagedorn) insulin lowers blood glucose within 1 to 2 hours after administration and exerts a peak effect at 6 to 10 hours. Endogenous insulin, a pancreatic hormone composed of two polypeptide chains, is important in the normal metabolism of carbohydrates, proteins and fats, promoting glucose utilization and protein synthesis; it has anabolic effects on many types of tissues. (NCI04) ( NCI )] (UMLS (NCI) C0021658) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
| - 2369. Integrin Alpha-V Beta-5 Protein
- (UMLS (NCI) C0083026) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor
|
- 2320. insulinlike factor
- [ ] (UMLS (CSP) C0596784) =Pharmacologic Substance ;
=antihyperglycemic;
| - 2370. Integrin Beta-4
- [Integrins are transmembrane glycoprotein receptors that mediate cell-matrix or cell-cell adhesion, and transduce signals that regulate gene expression and cell growth. They are heterodimeric molecules consisting of noncovalently linked alpha and beta subunits. All integrin subunits display a cytoplasmic domain that interacts with the cytoskeleton, a transmembrane region, and a large extracellular domain that interacts with the extracellular matrix. The ITGB4 extracellular domain shows 35% identify with other integrin beta subunits, but is the most different among this class of molecules. The transmembrane region is poorly conserved, whereas the cytoplasmic domain showed no substantial identity in any region to the cytoplasmic tails of other integrin beta sequences or to other protein sequences. The integrin alpha-6/beta-4, a receptor for the laminins, is likely to play a pivotal role in the biology of invasive carcinoma. (from OMIM) ( NCI )] (UMLS (NCI) C0253906) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
|
- 2321. insulinotropin
- [ ] (UMLS (CSP) C0063686) =Amino Acid, Peptide, or Protein
| - 2371. Integrin Beta-5
- [Human integrin beta-5 protein (799 aa, ~88 kD) is encoded by the integrin, beta 5 gene (ITGB5). This type I membrane protein forms a heterodimer with integrin alpha-V protein. The resulting complex binds to the tripeptide R-G-D, an amino acid sequence present in a number of ligands including vitronectin, fibronectin, fibrinogen, and laminin. Ligand binding regulates cell adhesion, growth and migration. ( NCI )] (UMLS (NCI) C0249042) =Amino Acid, Peptide, or Protein; Receptor ;
|
- 2322. Insurance
- [A mechanism for guarding against financial aspects of risk by making payments in the form of premiums to an insurance company, which pays an agreed-upon sum to the insured in the event of loss. ( NCI )] (UMLS (NCI) C0021672) =Idea or Concept
| - 2372. Integrin Binding
- [Integrin Binding involves a biophysical interaction between members of the Integrin family of heterodimeric receptors, that typically mediate cell-to-cell and cell-to-extracellular matrix interactions, and another biological molecule, such as a protein. Such interactions often induce alterations in signal transduction cascades that affect cell function. ( NCI )] (UMLS (NCI) C1149503) =Molecular Function ;
|
- 2323. insurance (nonhealth)
- [ ] (UMLS (CSP) C0599809) =Idea or Concept ;
| - 2373. Integrin, Alpha 5 (Fibronectin Receptor, Alpha Polypeptide) Gene
- [This gene is involved in receptor signaling and plays a role in cellular adhesion. ( NCI )] (UMLS (NCI) C1416488) ITGA5;
ITGA5 Gene;
=Gene or Genome |
- 2324. Insurance certification definition
- (UMLS (HL7) C1547362) =Idea or Concept =Data type;
| - 2374. Integrin, Alpha L (Antigen CD11A (p180), Lymphocyte Function-Associated Antigen 1; Alpha Polypeptide) Gene
- [This gene plays a role in leukocyte intercellular adhesion. ( NCI )] (UMLS (NCI) C1334144) ITGAL;
ITGAL Gene;
=Gene or Genome ;
|
- 2325. Insurance Company
- (UMLS (HL7) C1549448) =Idea or Concept =Contact Role;
Mail Claim Party;
Eligibility Source;
| - 2375. Integrin, Alpha M (Complement Component Receptor 3, Alpha; Also Known As CD11b (p170), Macrophage Antigen Alpha Polypeptide) Gene
- [This gene plays a role in extracellular matrix interactions and cellular adhesion. ( NCI )] (UMLS (NCI) C1366562) ITGAM;
ITGAM Gene =Gene or Genome |
- 2326. Insurance Company Contact Reason
- (UMLS (HL7) C1547638) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Medicare claim status;
Medicaid claim status;
Name/address change | - 2376. Integrin, Alpha V (Vitronectin receptor, Alpha Polypeptide, Antigen CD51) Gene
- [This gene plays a role in cell communication and angiogenesis. ( NCI )] (UMLS (NCI) C1416494) ITGAV;
ITGAV Gene;
=Gene or Genome |
- 2327. Insurance company ID codes
- (UMLS (HL7) C1547687) =Intellectual Product =HL7 Vocabulary Version 2.5;
| - 2377. Integrin, Alpha X (Antigen CD11C (p150), Alpha Polypeptide) Gene
- [This gene is involved in the initiation of immune cell chemotaxis and phagocytosis. ( NCI )] (UMLS (NCI) C1334145) ITGAX;
ITGAX Gene;
=Gene or Genome ;
|
- 2328. Insurance Plan ID
- (UMLS (HL7) C1550362) =Intellectual Product =HL7 Vocabulary Version 2.5;
| - 2378. Integrin, Beta 2 (Antigen CD18 (p95), Lymphocyte Function-Associated Antigen 1; Macrophage Antigen 1 (MAC-1) Beta Subunit) Gene
- [This gene is involved in the mediation of cellular adhesion and cell-surface signal transduction. ( NCI )] (UMLS (NCI) C1334146) ITGB2;
ITGB2 Gene;
=Gene or Genome ;
|
- 2329. Insurance, Health, Reimbursement
- [Payment by a third-party payer in a sum equal to the amount expended by a health care provider or facility for health services rendered to an insured or program beneficiary. (From Facts on File Dictionary of Health Care Management, 1988) ( MSH )] (UMLS (NCI) C0021684) =Health Care Activity
| - 2379. Integrin, Beta 3 (Platelet Glycoprotein IIIa, Antigen CD61) Gene
- [This gene plays a role in the mediation of platelet aggregation and wound repair. ( NCI )] (UMLS (NCI) C1416498) ITGB3;
ITGB3 Gene;
=Gene or Genome |
- 2330. Insured
- (UMLS (HL7) C1548605) =Intellectual Product =Disabled Person Code;
| - 2380. Integrin, Beta 4 Gene
- [This gene plays a role in cellular adhesion and extracellular matrix interactions. The gene has also been linked to carcinoma invasiveness through signal transduction pathways. ( NCI )] (UMLS (NCI) C1334147) ITGB4;
ITGB4 Gene;
=Gene or Genome ;
|
- 2331. Insured presented card
- (UMLS (HL7) C1549469) =Idea or Concept =Eligibility Source;
| - 2381. Integrin, Beta 5 Gene
- [This gene is involved in cell communication and signal transduction. ( NCI )] (UMLS (NCI) C1416501) ITGB5;
ITGB5 Gene;
=Gene or Genome |
- 2332. Insured presented policy
- (UMLS (HL7) C1549468) =Idea or Concept =Eligibility Source;
| - 2382. IntegrityCheckAlgorithm
- (UMLS (HL7) C1553730) =Intellectual Product =CodeSystem;
=secure hash algorithm - 1;
secure hash algorithm - 256 |
- 2333. INT ASTHMA W (AC) EXAC
- (UMLS (ICD9CM) C1176340) Intrinsic asthma with acute exacerbation =Disease or Syndrome ;
| - 2383. INTEGUMENT TISS SYMP NEC
- [ ] (UMLS (ICD9CM) C0159037) =Sign or Symptom
|
- 2334. INT ASTHMA W STATUS ASTH
- [ ] (UMLS (ICD9CM) C0155882) =Disease or Syndrome
| - 2384. Integumentary System Finding
- (UMLS (NCI) C1291044) =Finding ;
|
- 2335. INT DERANGEMENT KNEE NEC
- [ ] (UMLS (ICD9CM) C0158065) =Anatomical Abnormality
| - 2385. Integumentary System Part
- (UMLS (NCI) C1300680) =Body Part, Organ, or Organ Component
|
- 2336. INT DERANGEMENT KNEE NOS
- [ ] (UMLS (ICD9CM) C0158053) =Anatomical Abnormality
| - 2386. Integumentary System Signs and Symptoms
- [Patient complaints (symptoms), physical and/or laboratory findings related to the skin or integument. ( NCI )] (UMLS (NCI) C1334192) =Sign or Symptom ;
|
- 2337. INT DRAIN PANCREAT CYST
- [ ] (UMLS (ICD9CM) C0193599) =Therapeutic or Preventive Procedure
| - 2387. intein
- [self-calatytic protein splicing element; in-frame intervening sequence that disrupts a host gene and its protein product. ( CSP )] (UMLS (CSP) C1171311) =Amino Acid, Peptide, or Protein; Biologically Active Substance =gene product;
|
- 2338. INT FIX W/O FX REDUC NOS
- [ ] (UMLS (ICD9CM) C0376056) =Therapeutic or Preventive Procedure
| - 2388. intelligence
- [having the capacity to acquire thought and reason and apply knowledge. ( CSP )] (UMLS (CSP) C0021704) =Mental Process =Performance;
|
- 2339. INT FIX-NO FX REDUCT NEC
- [ ] (UMLS (ICD9CM) C0177418) =Therapeutic or Preventive Procedure
| - 2389. intended
- [The particpant intends to provide a signature. ( HL7V3.0 )] (UMLS (HL7) C1551357) =Idea or Concept =ParticipationSignature;
|
- 2340. INT FIXATION-CHEST CAGE
- [ ] (UMLS (ICD9CM) C0177417) =Therapeutic or Preventive Procedure
| - 2390. Intense
- [The degree or magnitude of strength, energy, or feeling. ( NCI )] (UMLS (NCI) C0522510) =Qualitative Concept
|
- 2341. INT FIXATION-HUMERUS
- [ ] (UMLS (ICD9CM) C0186771) =Therapeutic or Preventive Procedure
| - 2391. Intensive care
- [advanced and highly specialized care provided to medical or surgical patients whose conditions are life-threatening and require comprehensive care and constant monitoring; it is usually administered in specially equipped units of a hospital. ( CSP )] (UMLS (HL7) C0085559) =Health Care Activity ;
=hospital;
hospital patient care;
Level of Care;
=Coronary care unit;
neonatal intensive care;
◊ (UMLS (HL7) C1548354) Biomedical Occupation or Discipline Specialty Type; |
- 2342. INT FIXATION-METACAR/CAR
- [ ] (UMLS (ICD9CM) C0187442) =Therapeutic or Preventive Procedure
| - 2392. Intensive care unit
- (UMLS (HL7) C1549475) =Idea or Concept =Room type;
|
- 2343. INT FIXATION-METATAR/TAR
- [ ] (UMLS (ICD9CM) C0188844) =Therapeutic or Preventive Procedure
| - 2393. Intensive care unit
- (UMLS (HL7) C1610734) =Intellectual Product ;
=Hospital unit;
=Pediatric intensive care unit;
|
- 2344. INT FIXATION-RADIUS/ULNA
- [ ] (UMLS (ICD9CM) C0186901) =Therapeutic or Preventive Procedure
| - 2394. intent
- [An intention or plan to perform a service.Historical note: in previous RIM versions, the intent mood was captured as a separate class hierarchy, called Service_intent_or_order. ( HL7V3.0 )] (UMLS (HL7) C1550453) =Idea or Concept =ActMoodCompletionTrack;
=appointment;
resource slot;
request;
appointment request;
proposal;
promise |
- 2345. INT FIXATION-TIBIA/FIBUL
- [ ] (UMLS (ICD9CM) C0188260) =Therapeutic or Preventive Procedure
| - 2395. Intent
- [An anticipated outcome that is the meaning or purpose for actions taken, thus guiding your planned actions. ( NCI )] (UMLS (NCI) C1283828) =Mental Process
|
- 2346. INT HEMORRHOID W/O COMPL
- [ ] (UMLS (ICD9CM) C0265035) =Disease or Syndrome ;
| - 2396. Intent To Treat
- [Drug use is intended to improve a pre-existing disease or condition. ( NCI )] (UMLS (NCI) C1292734) Treat;
Treatment Intent =Functional Concept ;
|
- 2347. INT HEMRRHOID W COMP NEC
- [ ] (UMLS (ICD9CM) C0155782) =Acquired Abnormality ;
| - 2397. Inter
- (UMLS (HL7) C1548610) =Temporal Concept =Repeat;
|
- 2348. INT INF CLSTRDIUM DFCILE
- [ ] (UMLS (ICD9CM) C0494025) =Disease or Syndrome
| - 2398. Interacinar Cell Pancreatic Polypeptide
- [A 36-amino acid pancreatic hormone that is secreted mainly by endocrine cells found at the periphery of the ISLETS OF LANGERHANS and adjacent to cells containing SOMATOSTATIN and GLUCAGON. Pancreatic polypeptide (PP), when administered peripherally, can suppress gastric secretion, gastric emptying, pancreatic enzyme secretion, and appetite. A lack of pancreatic polypeptide (PP) has been associated with OBESITY in rats and mice. ( MSH )] (UMLS (NCI) C0030298) =Amino Acid, Peptide, or Protein; Neuroreactive Substance or Biogenic Amine; Hormone =pancreas hormone;
=amylin |
- 2349. INT INF E COLI ENTRHMRG
- (UMLS (ICD9CM) C0343381) =Disease or Syndrome
| - 2399. Interacting Therapy No Longer Active/Planned
- [Concurrent therapy triggering alert is no longer on-going or planned ( HL7V3.0 )] (UMLS (HL7) C1555294) =Intellectual Product =Therapy Appropriate;
|
- 2350. INT INF E COLI ENTRNVSV
- (UMLS (ICD9CM) C0343382) =Disease or Syndrome
| - 2400. Interaction
- (UMLS (HL7) C1546938) =Idea or Concept =Event Qualification;
|
home 
Armenian-English 
top